Navigation Links
Echosens: Launch of the FibroScan®502 Touch
Date:10/27/2011

PARIS, October 27, 2011 /PRNewswire/ --

Since its initial inception, Echosens has a history of innovation and it continues to widen and strengthen its product range with the recent introduction of the FibroScan® 502 Touch.

Equipped with a new and more ergonomic tactile interface, and based on patented Vibration-Controlled Transient Elastography (VCTE™), the latest FibroScan® provides a reliable, accurate and reproducible assessment of liver tissue stiffness.

This patented VCTE technology, developed by Echosens, is unique in measuring liver stiffness at a pre-determined and controlled 50 Hz frequency.

The FibroScan® 502 Touch offers enhanced patient data management with more complete and personalized exam reports. Compatible with the complete range of FibroScan probes (S+, M+ and XL+) it offers simultaneous connection of 2 probes giving flexibility for the patient assessment.  An indicator recommends the probe best suited to the patient's morphology.

Echosens' FS 502 Touch represents a quicker and more complete device built around the latest generation of electronics.

Continuing Echosens' history of innovation, the FS 502 Touch is further enhanced by the optional integration of the latest technological innovation: CAP™ (Controlled Attenuation Parameter), the new parameter for steatosis assessment and quantification.

Echosens has also launched new software for managing FibroScan® examinations: the Desk Solution. This comprehensive and innovative solution provides ready access to FibroScan assessments on the physician's desk-top PC.

Echosens products are widely available in most global markets and the company is actively pursuing the necessary FDA approvals to homologate its devices for sale in the United States.

About Echosens and Fibroscan®

FibroScan® is designed to quantify hepatic elasticity and steatosis in a non-invasive manner in chronic liver diseases assessment.

Founded in 2001, Echosens supplies its products in more than 70 countries through a global network of suppliers. It dedicates a major portion of its activity to research and development in order to invent new medical devices and open up new medical perspectives.  The organization works in close cooperation with health professionals and patients' associations to facilitate management and therapeutic monitoring of patients.  To date, there around 400 publications which attest to the efficacy of FibroScan in clinical practice.

Press Contact

ECHOSENS
Richard GUILLAUME
contact@echosens.com
+33-144-827850

 


'/>"/>
SOURCE Echosens
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. nContact, Inc. Launches New Corporate Websites
2. First Response Launches IVF Fundraising Resource for Those Trying for a Baby
3. Latest Pharmaceutical Launch Strategies Demonstrate Growing Importance of Thought Leader Engagement at Market Entry
4. CDC Launches Effort to Protect Cancer Patients From Infections
5. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
6. Gamma Pharmaceuticals, Inc., Launches Retail Promotions for Gamma Energy Gel™ in New York City and Houston
7. Recent Research Provides Formula for Timely Product Launch: Good Science + Effective FDA Relations
8. Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology
9. Arthrosurface Launches Worlds First Talus Resurfacing Implant for the Ankle
10. Medical Alarm and Harrington Multi Media Schedule Production for MediPendant™ National Television Launch
11. DYMO® Labeling Launches High-Resolution Identification Scanner for Health Records Processing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... A revolution is underway. Brooklyn-based company, ... for the millions of people who require these medical transport services annually. ... the use of technology. Now, SmartEMS has put forth an industry-changing app that ...
(Date:6/26/2016)... Aliso Viejo, California (PRWEB) , ... June 26, 2016 , ... ... for Final Cut Pro X. , "Film editors can give their videos a whole ... artistically," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Levels ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):